Skip to main content

Advertisement

Log in

A point-of-care chemiluminescence immunoassay for pepsinogen I enables large-scale community health screening

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

A Correction to this article was published on 09 July 2021

This article has been updated

Abstract

Pepsinogen I (PGI) can reflect the morphology and function of the gastric mucosa. Accordingly, the large-scale community health screening of PGI can dramatically increase the early diagnosis rate of gastric cancer. However, PGI testing can only be carried out in comprehensive hospitals and health examination centers. To ameliorate this issue, a point-of-care chemiluminescent immunoassay for PGI was developed in a fully automated miniaturized instrument. This instrument was especially developed for health check-ups in the grassroots communities; its volume of which is only 0.18 m3. Critically, the entire detection process for a single sample only requires 20 min, and the samples can be loaded continuously, making the method suitable for high-throughput analysis. The assay displayed an excellent detection limit of 0.048 ng/mL with a broad detection range of 0–200 ng/mL. Furthermore, this assay exhibited high sensitivity and specificity, had low intra- and inter-assay coefficients of variation (<10%), and was not affected after storage at 37 °C for 7 days. The assay was used to detect PGI in 95 clinical serum samples, and the results were highly correlated with those that were clinically tested (correlation coefficient, R2 = 0.998). Hence, the method established in this work has great application value and can be broadly applied for the large-scale screening of gastric cancer in resource-limited areas.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Change history

References

  1. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30:12–23.

    Article  Google Scholar 

  2. Parn M-L, Innos K, Baburin A, Kiivet R-A, Jaal J. Gastric cancer trends in Estonia 1995-2014 by age, subsite, morphology and stage. Acta Oncol. 2019;58(3):283–9.

    Article  Google Scholar 

  3. Wang K, Liang Q, Li X, Tsoi H, Yu J. MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome. Gut. 2015;65(10):1619–31.

    Article  Google Scholar 

  4. Wang Y, Zhu Z, Liu Z, Zhao Z, Xue X, Li X, et al. Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer. J Int Med Res. 2020;48(3).

  5. Mario FD, Cavallaro LG. Non-invasive tests in gastric diseases. Dig Liver Dis. 2008;40(7):523–30.

    Article  Google Scholar 

  6. Nardone G, Rocco A, Staibano S, Mezza E, Autiero G, Compare D, et al. Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther. 2005;22(11–12):1139–46.

    Article  CAS  Google Scholar 

  7. Cha JH, Jang JS. Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm. Korean J Intern Med. 2020;35(3):550–8.

    Article  Google Scholar 

  8. Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis. 2007;8(1):15–22.

    Article  CAS  Google Scholar 

  9. Huang SC, Miki K, Hirano K, Hayashi Y, Furihata C, Shimizu A, et al. Enzyme-linked immunosorbent assay of serum pepsinogen I. Clin Chim Acta. 1987;162(1):85–96.

    Article  CAS  Google Scholar 

  10. Banga-Mboko H, Sulon J, Closset J, Remy B, Youssao I, Sousa NMD, et al. An improved radioimmunoassay for measurement of pepsinogen in porcine blood samples. Vet J. 2003;165(3):288–95.

    Article  CAS  Google Scholar 

  11. Huang B, Xiao H, Zhang X, Zhu L, Liu H, Jin J. Ultrasensitive detection of pepsinogen I and pepsinogen II by a time-resolved fluoroimmunoassay and its preliminary clinical applications. Anal Chim Acta. 2006;571(1):74–8.

    Article  CAS  Google Scholar 

  12. Ogasawara D, Hirano Y, Yasukawa T, Shiku H, Kobori K, Ushizawa K, et al. Electrochemical microdevice with separable electrode and antibody chips for simultaneous detection of pepsinogens 1 and 2. Biosens Bioelectron. 2006;21(9):1784–90.

    Article  CAS  Google Scholar 

  13. Cho EJ, Kim HK, Jeong TD, Ko DH, Min WK. Method evaluation of pepsinogen I/II assay based on chemiluminescent immunoassays and comparison with other test methods. Clin Chim Acta. 2015;452:149–54.

    Article  Google Scholar 

  14. Nayak S, Blumenfeld NR, Laksanasopin T, Sia SK. Point-of-care diagnostics: recent developments in a connected age. Anal Chem. 2016;89(1):102–23.

    Article  Google Scholar 

  15. Wang Y, Dzakah EE, Kang Y, Cai Y, Wu P, Tang B, et al. A sensitive and rapid chemiluminescence immunoassay for point-of-care testing (POCT) of copeptin in serum based on high-affinity monoclonal antibodies via cytokine-assisted immunization. Int J Nanomedicine. 2019;14:4293–307.

    Article  CAS  Google Scholar 

  16. Qu Z, Wang K, Alfranca G, Fuente JM, Cui D. A plasmonic thermal sensing based portable device for lateral flow assay detection and quantification. Nanoscale Res Lett. 2020;15(1):10.

    Article  CAS  Google Scholar 

  17. Poschenrieder A, Thaler M, Junker R, Luppa PB. Recent advances in immunodiagnostics based on biosensor technologies—from central laboratory to the point of care. Anal Bioanal Chem. 2019;411(7):7607–21.

    Article  CAS  Google Scholar 

  18. Song M, Camargo MC, Weinstein SJ, Murphy G, Freedman ND, Koshiol J, et al. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Aliment Pharmacol Ther. 2018;47(4):494–503.

    Article  CAS  Google Scholar 

  19. Liu R, Wang C, Jiang Q, Zhang W, Liu G. Magnetic-particle-based, ultrasensitive chemiluminescence enzyme immunoassay for free prostate-specific antigen. Anal Chim Acta. 2013;801(4):91–6.

    Article  CAS  Google Scholar 

  20. Fu X, Liu Y, Qiu R, Foda MF, Zhang Y, Wang T, et al. The fabrication of magnetic particle-based chemiluminescence immunoassay for human epididymis protein-4 detection in ovarian cancer. BB Reports. 2018;13:73–7.

    PubMed  PubMed Central  Google Scholar 

  21. Lin Z, Wang X, Li ZJ, Ren SQ, Chen GN, Ying XT, et al. Development of a sensitive, rapid, biotin-streptavidin based chemiluminescent enzyme immunoassay for human thyroid stimulating hormone. Talanta. 2008;75(4):965–72.

    Article  CAS  Google Scholar 

  22. Rodriguez-Orozco AR, Ruiz-Reyes H, Medina-Serriteno N. Recent applications of chemiluminescence assays in clinical immunology. Mini-Rev Med Chem. 2010;10(14):1393–400.

    Article  CAS  Google Scholar 

  23. Li Y, Ji X, Liu B. Chemiluminescence aptasensor for cocaine based on double-functionalized gold nanoprobes and functionalized magnetic microbeads. Anal Bioanal Chem. 2011;401(1):213–9.

    Article  CAS  Google Scholar 

  24. Tudorache M, Zdrojewska IA, Emnéus J. Evaluation of progesterone content in saliva using magnetic particle-based immuno supported liquid membrane assay (m-ISLMA). Biosens Bioelectron. 2007;22(2):241–6.

    Article  Google Scholar 

  25. Dungchai W, Siangproh W, Lin JM, Chailapakul O, Lin S, Ying X. Development of a sensitive micro-magnetic chemiluminescence enzyme immunoassay for the determination of carcinoembryonic antigen. Anal Bioanal Chem. 2007;387(6):1965–71.

    Article  CAS  Google Scholar 

  26. Wang Y, Dzakah EE, Kang Y, Cai Y, Wu P, Cui Y, et al. Development of anti-Mullerian hormone immunoassay based on biolayer interferometry technology. Anal Bioanal Chem. 2019;411(21):5499–507.

    Article  CAS  Google Scholar 

  27. Luxton R, Badesha J, Kiely J, Hawkins P. Use of external magnetic fields to reduce reaction times in an immunoassay using micrometer-sized paramagnetic particles as labels (magnetoimmunoassay). Anal Chem. 2004;76(6):1715–9.

    Article  CAS  Google Scholar 

  28. Zhu D, Tang Y, Xing D, Chen WR. PCR-free quantitative detection of genetically modified organism from raw materials. An electrochemiluminescence-based bio bar code method. Anal Chem. 2008;80(10):3566–71.

    Article  CAS  Google Scholar 

  29. Jie M, Yu S, Yu F, Liu L, He L, Li Y, et al. An ultrasensitive chemiluminescence immunoassay for fumonisin B-1 detection in cereals based on gold-coated magnetic nanoparticles. J Sci Food Agric. 2018;98(9):3384–90.

    Article  CAS  Google Scholar 

  30. Gillet P, Mori M, Van Esbroeck M, Van den Ende J, Jacobs J. Assessment of the prozone effect in malaria rapid diagnostic tests. Malar J. 2009;8:271.

    Article  Google Scholar 

  31. Singh S, Mishra P, Banga I. A SP, Prakash TP, Gandhi S. Chemiluminescence based immunoassay for the detection of heroin and its metabolites. Bioimpacts. 2018;8(1):53–8.

    Article  CAS  Google Scholar 

  32. Chen, Zong, Duoduo, Zhang, Fan, Jiang, et al. Metal-enhanced chemiluminescence detection of C-reaction protein based on silver nanoparticle hybrid probes. Talanta. 2019;199:164–9.

  33. Chang Y, Xu J, Zhang Q. Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer. Oncol Lett. 2017;14(4):4043–52.

    Article  Google Scholar 

  34. Feng X-L, Ren H-L, Li Y-S, Hu P, Zhou Y, Liu Z-S, et al. A magnetic particles-based chemiluminescence enzyme immunoassay for rapid detection of ovalbumin. Anal Biochem. 2014;459:12–7.

    Article  CAS  Google Scholar 

  35. Jiang W, Sun G, Zhang Y, Hu Z, Wen X, Men S, et al. Simultaneous determination of gastric cancer biomarkers pepsinogen PGI/PGII using element tagged immunoassay coupled with inductively coupled plasma mass spectrometry detection. J Clin Lab Anal. 2020;34(7):e23287.

    Article  CAS  Google Scholar 

  36. Khramtsov P, Barkina I, Kropaneva M, Bochkova M, Timganova V, Nechaev A, et al. Magnetic nanoclusters coated with albumin, casein, and gelatin: size tuning, relaxivity, stability, protein corona, and application in nuclear magnetic resonance immunoassay. Nanomaterials. 2019;9(9):1345.

    Article  CAS  Google Scholar 

  37. Crowther JR. The ELISA guidebook. Methods in molecular biology (Clifton, NJ). 2000;149:III-IV, 1–413.

  38. Yang HJ, Bever CS, Zhang HY, Mari GM, Li HF, Zhang XY, et al. Comparison of soybean peroxidase with horseradish peroxidase and alkaline phosphatase used in immunoassays. Anal Biochem. 2019;581:9.

    Article  Google Scholar 

Download references

Funding

This work was supported by the Science and Technology Program of Guangdong Province (2021B1212050016), the Postdoctoral Scientific Research Project of Guangzhou (BHSKY20200301), the R & D Project in key areas of Guangdong Province (2020B1111160004), and Guangzhou Science and Technology Program (201902010003, 201802010030).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiaowei He or Yu Wang.

Ethics declarations

Ethics approval

The clinical serum and plasma samples were approved by the Research Ethics Committee of Third Affiliated Hospital of Guangzhou University of Chinese Medicine (AF/SC-08/02.0), and the study was performed in accordance with the relevant guidelines.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

"The original online version of this article was revised: The last name of the coauthor (Jingjing Zhou) has been wrongly written, which should be ‘Zou’ instead of ‘Zhou’." plus the same explanatory text of the problem as in the erratum/correction article

Supplementary information

ESM 1

(PDF 523 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, F., Zou, J., Luo, X. et al. A point-of-care chemiluminescence immunoassay for pepsinogen I enables large-scale community health screening. Anal Bioanal Chem 413, 4493–4500 (2021). https://doi.org/10.1007/s00216-021-03412-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-021-03412-6

Keywords